Physician profile
David Sining Chen
NPI 1952672289
$2,224.00
in general payments reported to CMS, 2019-2025
9 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $253 · 2022: $679 · 2023: $214 · 2024: $738 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $670.83 | 2022-2024 | |
| Depuy Synthes Sales INC. | $594.18 | 2021-2025 | Trumatch, Na, Matrixmidface |
| Stryker Corporation | $341.47 | 2022-2024 | Na |
| Dompe US, INC. | $124.98 | 2022 | |
| Genzyme Corporation | $121.44 | 2022-2024 | |
| Baxter Healthcare | $120.12 | 2019 | |
| Genentech USA, INC. | $117.04 | 2022 | |
| Axogen | $104.39 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $29.55 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.